Cotización Scinai Immunotherapeutics - SCNI

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

3.30

Postura de Compra

3.05

Postura de Venta

3.55

Volume Operado de la Acción

3,060

3.25 Rango del Día 3.40

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

2.763M

Precio Anterior

3.28

Precio de Apertura

3.25

Hora

3.25

Última hora de negociación

15:00:00

Volumen financiero

US$ 10,123

Precio Promedio Ponderado

3.3081

Volumen promedio (3 m)

Acciones en circulación

837,310

Rendimiento del Dividendo

Ratio Precio/Utilidad

0.00

Beneficio por acción (BPA)

turnover

Beneficio neto

-6.5M

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic ... BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic. Mostrar más

Sector

Biological Pds,ex Diagnstics

Industria

Coml Physical, Biologcl Resh

Sitio web

www.biondvax.com

Sede

Jerusalem, Jerusalem, Isr

Fundado

2012

Scinai Immunotherapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SCNI. The last closing price for Scinai Immunotherapeutics was US$3.28. Over the last year, Scinai Immunotherapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Scinai Immunotherapeutics currently has 837,310 shares in issue. The market capitalisation of Scinai Immunotherapeutics is US$2.75 million.

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT PR Newswire JERUSALEM, March...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences PR Newswire JERUSALEM, Jan...

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc. PR...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

SCNI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Scinai Immunotherapeutics?

El precio actual de las acciones de Scinai Immunotherapeutics es US$ 3.30

¿Cuántas acciones de Scinai Immunotherapeutics están en circulación?

Scinai Immunotherapeutics tiene 837,310 acciones en circulación

¿Cuál es la capitalización de mercado de Scinai Immunotherapeutics?

La capitalización de mercado de Scinai Immunotherapeutics es USD 2.75M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Scinai Immunotherapeutics?

Scinai Immunotherapeutics ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

¿Cuál es la moneda de reporte de Scinai Immunotherapeutics?

Scinai Immunotherapeutics presenta sus resultados financieros en USD

¿Cuál es el último ingresos anual de Scinai Immunotherapeutics?

El último ingresos anual de Scinai Immunotherapeutics es USD 9k

¿Cuál es el último beneficio anual de Scinai Immunotherapeutics?

El último beneficio anual de Scinai Immunotherapeutics es USD -6.5M

¿Cuál es la dirección registrada de Scinai Immunotherapeutics?

La dirección registrada de Scinai Immunotherapeutics es JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, JERUSALEM, 7403618

¿Cuál es la dirección del sitio web de Scinai Immunotherapeutics?

La dirección del sitio web de Scinai Immunotherapeutics es www.biondvax.com

¿En qué sector industrial opera Scinai Immunotherapeutics?

Scinai Immunotherapeutics opera en el sector COML PHYSICAL, BIOLOGCL RESH

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
HCTIHealthcare Triangle Inc	US$ 0.4978 (53.17%)	13.65M
SSPEW Scripps Company	US$ 1.97 (37.76%)	874.16k
SFIXStitch Fix Inc	US$ 5.11 (20.80%)	2.15M
ONEGOneConstruction Group Limited	US$ 2.71 (20.44%)	1.29k
PALIPalisade Bio Inc	US$ 1.12 (19.15%)	94.66k
SHLTSHL Telemedicine Ltd	US$ 1.65 (-36.54%)	6.19k
HEPAHepion Pharmaceuticals Inc	US$ 0.0539 (-35.83%)	22.6M
SYRSSyros Pharmaceuticals Inc	US$ 0.1018 (-25.15%)	5.26M
ZYXIZynex Inc	US$ 5.47 (-21.86%)	21.25k
TNONTenon Medical Inc	US$ 1.21 (-19.87%)	1.27M
HEPAHepion Pharmaceuticals Inc	US$ 0.0539 (-35.83%)	22.6M
HCTIHealthcare Triangle Inc	US$ 0.4978 (53.17%)	13.65M
SYRSSyros Pharmaceuticals Inc	US$ 0.1018 (-25.15%)	5.26M
ICONIcon Energy Corporation	US$ 0.107 (-6.96%)	5.2M
NVDANVIDIA Corporation	US$ 109.20 (0.40%)	4.92M

jimr1717 6 minutos hace

I think “AL” was lying.

“ Let’s go with AI’s predictions.”

Low .06
Mid .22
High .39

Lmao

HMBL

THEBEASTMUGABI 7 minutos hace

Good information, thank you for posting.

IONQ

ramfan60 7 minutos hace

That would be phenomenal .......

AMRN

alexbh2285 7 minutos hace

I’m not surprised. Con artists are usually very entertaining / charismatic.

ALYI

blackcat 8 minutos hace

Probably a good thing. He likely thinks Rules of the Road don't apply to him either.

I suppose his granddaughter wanted a Tesla? They're all MAGA too, no doubt.

cervelo 8 minutos hace

Going at it like a real company. Unlike pete going at it like shareholder funds are his personal savings account. Still wonder what pete does to justify paying himself over 20 times what the president of the USA gets.

AUPH

Jimmy Joe 9 minutos hace

Time to put some teeth in regulations!!!!!!!!!!!!!!!!!!!!!!!!!!

What did Trump just say the other day~? They want to eliminate regulations. Already too many regulations according to his administration.

Canada and Mexico are our new enemies because this isn't a tariff w

AMC

jour_trader 9 minutos hace

I don't think tariffs are going to add much value in a sale. Trump administration's stance is starting to weaken on tariffs due to chaos it's causing. They will come down and ultimately go away. Just a matter of time.

ELTP

jimr1717 9 minutos hace

Ouch sorry

HMBL

DarthYoda 9 minutos hace

Cryptos bounced because the top pumpers had another public pumper meeting. How many more times will they try to inform us about this? They made sure to time it with the gap fill too lol. They are consciously NOT trying to make life cheaper for Americans while focusing on pumping digital air to enric

XRPUSD

NebraskaOTC 9 minutos hace

Once again.... still NO $BMXI AUDIT!!! :-D

BMXI

Legend431 10 minutos hace

I think more relatable to NWBO is to ask:

Where is Michael Bigger and Carlo Rago?

Where is Linda power and Les Goldman?

Where is LL and the other couple of Doctors?

NWBO

XMaster2023 10 minutos hace

Perhaps if Ken Griffin and his 6 friends get thrown in a Federal Prison we can pull together a Bonus for Cofer Black?
For his service in the CIA, he was awarded the highest award of honor, the Distinguished Intelligence Medal.

NWBO

bubba412 10 minutos hace

lol Nothing for me to eat crow about

ELTP

DesktopDR 10 minutos hace

Yes, the moderators ruined it.

VPLM

spdpro 10 minutos hace

Can Kicked > Onward > House Passes Full-Year Stopgap

Gunny 11 minutos hace

Until CRTG is traded OTC the price is irrelevant. The price once CRTG returns to OTC trading or better yet on the NASDAQ is the only price that effects us.

CRTG

flipper44 11 minutos hace

So you are accusing her of intentionally lying.

NWBO

oystersnbeer 11 minutos hace

And now a look at the Stock Market..

https://youtu.be/pj8rrhBANSg

satter 11 minutos hace

Nice to know Eric was lying all this time how Mr Pearlman was out to destroy WNBD and would not even consider an offer without some payment first. What a lie that was after he continued to bash the creditor on Twitter.

Good news for the creditor he finally gets some funds and

WNBD

Jaguarjacket 12 minutos hace

Yup, staying on track. Expansion happening

ADIA

fuagf 12 minutos hace

You're right it's again about a more powerful country getting exploitive access to a smaller country's resources, and of course as always that's not all it's about. I've heard some of the Ukrainian territory occupied by Russian is mineral-rich so that's part of the deal. Didn't get to that with thi

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Scinai Immunotherapeutics Ltd (SCNI)

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Acerca de Scinai Immunotherapeutics Ltd

SCNI Últimas noticias

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

SCNI - Preguntas Frecuentes

Movimientos

SCNI Finanzas

Discusión

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Scinai Immunotherapeutics Ltd (SCNI) Cotización

Scinai Immunotherapeutics Ltd (SCNI)

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Acerca de Scinai Immunotherapeutics Ltd

SCNI Últimas noticias

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

SCNI - Preguntas Frecuentes

Movimientos

SCNI Finanzas

Discusión

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR